Compliance With LDL-Lowering Therapy For Secondary Prevention of Coronary Heart Disease in Real Life Practice
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 555
- 主要终点
- percentage of patients reaching target LDL levels
研究概览
简要总结
This observational study is being conducted in patients receiving statin treatment as secondary prevention of coronary heart disease under the current standard of care in compliance with European guidelines. The purpose of the study is to evaluate the percentage of these patients that reach target LDL levels. Additionally this study will measure the patient's compliance to treatment as assessed by counting the returned tablets. Both assessments will be made at visits conducted 6-8 weeks after the first visit and 28-32 weeks after the first visit.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •willingness to participate in the study
- •18 years of age or more
- •clinically established cardiovascular disease to be considered as patients in secondary prevention
- •prior therapy with any statin without achieving goal (2.5 mmol/L of LDL cholesterol) at last lipid check performed
排除标准
- 未提供
研究组 & 干预措施
Patients with coronary heart disease
Patients being treated with a statin for secondary prevention of coronary heart disease
干预措施: Statin (Drug)
结局指标
主要结局
percentage of patients reaching target LDL levels
时间窗: 6-8 weeks after first visit and 28-32 weeks after first visit
次要结局
- measure patient compliance to treatment as assessed by counting returned tablets(6-8 weeks after first visit and 28-32 weeks after first visit)